Drug Topics
APRIL 8, 2025
In a comprehensive review, researchers aimed to explore seasonality, environmental factors, and the genetic and epigenetic mechanisms of patients living with psoriasis vulgaris.
The FDA Law Blog
APRIL 8, 2025
By Kurt R. Karst The FDA Reduction-in-Force (Termination)or RIF(T)announced last week has resulted in countless stories in the press and on personal LinkedIn accounts from those RIFd. As the dust begins to settle and we all assess what this means for the future of FDA and the public health, generally, this blogger wanted to call out one particular division in the Office of Generic Drugs (OGD), funded by user fees under the Generic Drug User Fee Amendments (GDUFA), that was eradicated and what t
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
APRIL 8, 2025
In a review of skin inflammations link to food allergen sensitivity, researchers explored how patients with atopic dermatitis may be more susceptible to the development of food allergies.
STAT
APRIL 8, 2025
Last week’s layoffs across the Department of Health and Human Services left a significant casualty in the vast ecosystem of government-backed science: an entire division focused on researching pain. The reduction in force enacted last week by Health Secretary Robert F. Kennedy Jr. eliminated all but one full-time position, out of roughly a dozen, within the National Institutes of Health Office of Pain Policy and Planning, a unit devoted to coordinating pain-related research across t
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
APRIL 8, 2025
Conflicting study findings show various associations between asthma and COVID-19; further data are needed.
STAT
APRIL 8, 2025
Editor’s note: This story contains a description of self-harm. Oncologist Mark Lewis has never had much of a poker face. When he walked into his cancer patient’s visit in 2022, he was wearing a big smile: The nodules in his patient’s lungs, he saw in the radiology report, were shrinking in response to treatment. His patient, though, was already upset.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmafile
APRIL 8, 2025
The Scottish Medicines Consortium (SMC) has accepted the use of Ipsens Iqirvo (elafibranor) in NHS Scotland for the treatment of primary biliary cholangitis (PBC), a rare liver disease. This marks the first new medicine for PBC to be accepted by the medical body in nearly a decade. Iqirvo is a peroxisome proliferator activated receptor (PPAR) […] The post Ipsens Iqirvo approved for use in NHS Scotland to treat rare liver disease appeared first on Pharmafile.
Drug Topics
APRIL 8, 2025
In part 3 of our interview with Jenny Markell, BA, she discussed drug advertising trends among Alzheimers disease drugs and how FDA suggestions are not necessarily followed.
Hospital Pharmacy Europe
APRIL 8, 2025
A digital self-assessment tool designed to help hospital pharmacy teams take practical action to support sustainability and reduce the environmental impact of pharmacy services, pharmaceutical care and medicines, while supporting patient care, has been launched by the Royal Pharmaceutical Society (RPS). The long-awaited RPS Greener Pharmacy Guide and Toolkit provides prompts to introduce more sustainable practices to reduce emissions, improve patient care, prevent ill health, tackle medicines wa
Drug Topics
APRIL 8, 2025
There were no statistically significant differences between cognitive behavioral therapy and mindfulness-based therapy in reducing the dosage for chronic lower back pain.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmafile
APRIL 8, 2025
High Force Research has announced that it has appointed Nathalie Huther as its first chief commercial officer (CCO) following the companys recent management buyout (MBO). This forms an important part of its business development and market expansion strategy. Huther will lead High Forces research commercial strategy, and brings a wealth of experience in commercial leadership […] The post High Force Research appoints Nathalie Huther as chief commercial officer appeared first on Pharmafile.
European Pharmaceutical Review
APRIL 8, 2025
GSK has agreed to develop novel medicines for neurodegenerative diseases, as part of a global licensing agreement with ABL Bio Inc, for up to 2.075 billion. This is subject to certain milestone payments across multiple potential programmes.The licensing deal will utilise ABL Bios blood-brain barrier shuttle platform Grabody-B, to advance multiple programmes across therapeutic modalities including antibody , polynucleotide or oligonucleotides, such as siRNA and ASOs.
Pharmafile
APRIL 8, 2025
ELRIG, a non-profit volunteer-led organisation dedicated to the drug discovery community, has appointed Del Trezise as chair of the board. He succeeds Melanie Leveridge, who completed her four-year term as chair. He will lead ELRIGs mission to deliver highly accessible scientific meetings and conferences. It serves a global network of over 22,000 life sciences professionals. […] The post ELRIG appoints Del Trezise as chair appeared first on Pharmafile.
Pharmacy Times
APRIL 8, 2025
Advanced practice provider (APP) care models allow for health systems to better individualize care for patients, effectively meeting their needs.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PharmaVoice
APRIL 8, 2025
Five years ago, Michelle Werner received her son’s Duchenne muscular dystrophy diagnosis with fear and desperation. Now, as CEO of Alltrna, she’s finding ways to turn those feelings into a better way of treating rare diseases.
Pharmacy Times
APRIL 8, 2025
The HERCULES trial demonstrates tolebrutinib's potential to slow disability progression in non-relapsing secondary progressive multiple sclerosis, offering a new treatment option for patients with limited therapeutic choices.
Pharmaceutical Technology
APRIL 8, 2025
Ethris has partnered Lonza for the development of room-temperature stable mRNA vaccine candidates targeting respiratory conditions.
Pharmacy Times
APRIL 8, 2025
Small changes in blood pressure and pulse were shown in patients of all ages, and the authors suggested that these are monitored carefully in patients being treated for ADHD.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Technology
APRIL 8, 2025
The European Commission (EC) has granted approval for the extension of indication for Janssen-Cilag Internationals Darzalex SC formulation.
Pharmacy Times
APRIL 8, 2025
The approval was based on efficacy and safety data from a randomized, 3-arm, open-label phase 3 CHECKMATE-8HW trial.
pharmaphorum
APRIL 8, 2025
European Commission President Ursula von der Leyen is scheduled to meet with EU pharma leaders today about how to respond to US tariffs.
Pharmacy Times
APRIL 8, 2025
Erin Harrell, PharmD, offers insights about managing peripheral neuropathy in patients receiving bortezomib.
pharmaphorum
APRIL 8, 2025
AbbVie has picked up another indication for its JAK inhibitor Rinvoq in the EU, becoming the first approved oral therapy for giant cell arteritis
Fierce Healthcare
APRIL 8, 2025
Consumers are using their insurers' websites, mobile apps and other digital platforms in greater numbers, but their experiences often fall short of expectations, according to a new report.
STAT
APRIL 8, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. In case you missed it yesterday, we have a winner for this year’s STAT Madness competition. From the same institution as last year — is that a dynasty I see forming?
pharmaphorum
APRIL 8, 2025
Brainomix has been granted FDA approval for a new feature for its AI-powered stroke imaging software that could unlock wider use in the US.
Pharmacy Times
APRIL 8, 2025
Pharmacy professionals gathered at the American Pharmacists Association 2025 Annual Meeting and Exposition and discussed critical insights in interviews with Pharmacy Times.
Fierce Healthcare
APRIL 8, 2025
With a sign-off from Connecticut's health regulator in hand, the nonprofits say they have a clear path toward closing their merger within the next 30 days.
Pharmacy Times
APRIL 8, 2025
Numerical differences were observed as early as Month 1.
Fierce Healthcare
APRIL 8, 2025
Go-to conservative judiciary Matthew Kacsmaryk tossed requirements for greater nurse staffing levels, writing in his judgment that HHS had exceeded its statutory authority and congressional intent.
pharmaphorum
APRIL 8, 2025
AstraZeneca and Daiichi Sankyo have claimed approval from the European Commission for Datroway, their TROP2-directed ADC for breast cancer.
Pharmacy Times
APRIL 8, 2025
Sophie Jabban discusses research presented at the SGO Annual Meeting highlighting significant disparities in MRI access for patients with cervical cancer receiving chemoradiation, with delays linked to both race and insurance status, underscoring systemic barriers that may impact timely treatment.
Pharmaceutical Commerce
APRIL 8, 2025
The conferences opening keynote case study shares ways to elicit change that not only results in business growth and productivity, but a boost in patient connection as well.
Expert insights. Personalized for you.
492 
Let's personalize your content